[Oxygen therapy and other pneumological tools for home use in Barcelones Nord i Maresme. A descriptive study]

[Quality of initial prescription of home oxygen therapy in a healthcare area of the Murcia Region (Spain)]

OBJECTIVE

To analyse the quality of the prescription of home oxygen therapy (OT) in a health area of Murcia.

METHODS

A prospective study of 125 patients in a respiratory therapy clinic, evaluated with a questionnaire and blood-gas analysis while breathing ambient air. Related respiratory therapy was also assessedin COPD and asthma patients.

RESULTS

We studied 125 cases in the 3 months following the prescription of home oxygen therapy in 72 men (58%) and 53 women (42%) with a mean age of 77.2 ± 11.6. The most common type of home OT prescribed was for palliative cases in 45 patients (36%), followed by COPD in 42 (33.6%). In 88 (92%) of the 96 medical reports that we evaluated, insufficient data as to how to administer oxygen were available. Twenty-five percent of home OT prescriptions were given without blood-gas analyses, and in the 65 cases with a blood-gas analysis only 11 (17%) met oxygen value criteria for home OT as per regulations. Oxygen desaturation was not present in 31% of the palliative care home OT cases. The analysis of blood-gases during the clinic visit in non-palliative care cases demonstrated that 61% did not meet the blood-gas criteria to continue on home OT. Eighty percent of COPD and asthma patients on home OT did not receive the correct respiratory therapy.

CONCLUSIONS

Quality problems in the prescription of home OT exist in our area. Palliative care is the principal reason for home OT prescriptions. In COPD and asthma patients who receive home OT, related respiratory therapy is not ideal.

[The results of the operation of a monitoring unit for home oxygen therapy]

OBJECTIVE

This study aims to a) analyze the prevalence of domiciliary oxygen therapy (DOT) in Mallorca, b) evaluate the cost effectiveness of the DOT monitoring unit, and c) determine the survival of patients with chronic obstructive pulmonary disease who are presently receiving DOT.

METHOD

When the DOT unit was created in April 1994, the situation of all patients receiving DOT in Mallorca was assessed in a transversal study. Over the next three years, these patients were reassessed regularly and all new prescriptions were evaluated (longitudinal study).

RESULTS

Before the unit began work, DOT was prescribed for 71 out of 100,000 inhabitants. DOT was withdrawn from 31% of patients assessed in the transversal study. By the end of the longitudinal study, DOT was being prescribed at a rate of 56 times per 10,000 inhabitants. The activities of the DOT unit brought about annual savings of approximately 38 million pesetas. The number of patients with liquid oxygen and concentrators increased such that the latter has become the main delivery system. The survival of COPD patients with DOT in this study seems to be longer than report.

CONCLUSIONS

a) The prevalence of DOT use in Mallorca before the DOT unit began operating was too high. b) The cost effectiveness of DOT monitoring is positive because DOT use has been optimized and significant savings have ensued (= 38 millions pesetas/year). c) The survival of COPD patients receiving DOT at present appears better than that reported in the literature, possibly related to the greater efficacy of modern treatment.

[Usefulness of home visits in the control and evaluation of the appropriate use of home continuous oxygen therapy]

The aim of this study was to determine the usefulness of home visits to monitor and evaluate the appropriate use of domiciliary oxygen therapy (DOT). Appropriateness was based on the coincidence of circumstances needed to predict benefit from DOT: appropriate indications correct hypoxemia and patient compliance. All patients receiving DOT residing in the town of L'Hospitalet (Barcelona) in June 1994 were enrolled. During a home visit to each patient a questionnaire was administered and spirometric variables, CO in exhaled air and pulse oximetry were recorded. If DOT was not considered appropriate, the patient was referred to the hospital clinic for reevaluation of the prescription. One hundred twenty-eight patients (74% men) were visited. Mean age was 68 years. Use of DOT was seen to be appropriate in only 26% of patients. The prescription of DOT was considered strictly correct in 73 patients (49%); 13 of them were seen to have continued smoking. Of the 60 remaining patients, hypoxemia was correct with oxygen therapy in 46, and of these only 33 complied with DOT. The home visit combined with hospital monitoring allowed us to withdraw DOT from 20 patients, for whom the indications had been incorrect, and to introduce changes in oxygen supply sources for 16 patients who carried pumps. Fourteen started using a concentrator and 2 began using liquid oxygen. Periodic review is necessary for optimal treatment of DOT. The home visit is a good tool for improving DOT follow-up, as it allows the patient to be assessed in the setting where DOT is really applied. It is a monitoring method that is well accepted by the patient.

Quality of life in severe chronic obstructive pulmonary disease: correlation with lung and muscle function

Chronic obstructive pulmonary disease (COPD) patients suffer from significant impairment in quality of life (QL), but the variables related to this impairment are not well known. The aim of this study has been to identify physiological parameters related to QL in severe COPD patients undergoing long-term oxygen therapy.

MATERIALS AND METHODS

We studied 47 COPD patients using long-term oxygen therapy (43 men/four women, 65.17 SD 8.21 years, 3.17 SD 2.61 years on oxygen). The Nottingham Health Profile (NHP) and activities of daily living (ADL) questionnaire were used to measure QL. Subjective assessment of dyspnoea was performed using a visual analogue scale. The physiological parameters determined were lung function (spirometry, arterial blood gases, lung volumes and carbon monoxide diffusing capacity), muscle function (maximum inspiratory and expiratory pressures, deltoid muscle and handgrip strength), and nutrition status (tricipital skin fold and mid-arm muscle circumference).

RESULTS

High ADL (8.32 SD 6.97) and NHP scores (energy 63.3 SD 40.43, pain 35.11 SD 31.56, emotional reactions 43.03 SD 25.13, sleep 51.91 SD 32.75, social isolation 30.64 SD 26.98, physical mobility 49.73 SD 24.93) demonstrated clinically significant QL impairment in the severe COPD patients studied. Stepwise multiple regression analysis found a correlation between lung function and QL. Low FEV1% was associated with impairment in energy, physical mobility and social isolation NHP scores and ADL score (r = -0.3, P < 0.05). RV/TLC also correlated with ADL and social isolation scores (r = 0.3, P < 0.05). Lung function explained 39-45% of the variation in these QL dimensions. QL did not correlate with other lung function parameters, muscle function or nutrition status.

CONCLUSION

COPD patients using long-term oxygen suffer from severe QL impairment affecting not only energy and mobility but also emotional reactions, social isolation and sleep. Lung function is related to energy, mobility and social isolation dimensions, but muscle function is unrelated to QL in these patients.

[Continuous domiciliary oxygen therapy in Zaragoza: a cross-sectional home study]

To assess use of long-term domiciliary oxygen therapy (LDOT) in Saragossa by means of home interviews. We conducted a cross-sectional study of patients undergoing LDOT, interviewing 312 of the 614 patients who used O2 at home in January 1993 (103/100,000 h). Health care workers visited the patients at home and collected all available information related to indications, pattern of use of O2 and complementary tests done. The interviewer also took spirometric readings, SaO2 readings breathing room air and after 30 min breathing O2, and administered a quality of life questionnaire (only to patients with pneumopathies). All patients selected were assessed; 195 (62.5%) suffered from chronic obstructive pulmonary disease (COPD), 33 (10.6%) from asthma, 31 (9.9%) from other pneumopathies, and 53 (17%) from a variety of conditions that were not primarily bronchopulmonary. Thirty-six (11.5%) were active smokers. Only 101 of the 184 patients for whom arterial gasometric readings were available met the criteria for prescribing LDOT. SaO2 without O2 was > or = 92% in 89 (28.5%) patients and > or = 90% in 193 (61.8%). Only 96 (31%) patients reported using O2 more than 15 hours/day and there was a weak inverse relation (p = 0.04) between hours of use and FEV1 in the COPD group. Quality of life for patients with pneumophaties depended entirely on degree of lung function deterioration and was unrelated to use of O2. The rate of use of LDOT Saragossa is one of the highest in Spain. In an estimated 28.5-46% of cases, the indications are inappropriate, mainly due to infrequent use of arterial gas measurement and the prescription of LDOT for patients without COPD. This situation largely explains why patients hardly ever use LDOT on a daily basis.